With this study, we aim to show that Cogwear’s technology can effectively detect changes in the brain areas critical for executive function and memory retention.
Cogwear Launches First Participants in Pilot Study
We are pleased to share that we have enrolled the first participants in our pilot study for Alzheimer’s detection. This project is especially close to our hearts, as we remember Carol, David’s mother-in-law, who bravely battled Alzheimer's. Her journey inspires our mission to bring hope and early detection to others facing this disease. With this study, we aim to show that Cogwear’s technology can effectively detect changes in the brain areas critical for executive function and memory retention. Our hope is to one day give patients, doctors, and families an easy way to accurately detect and diagnose Alzheimer’s early, so patients can seek treatment sooner (when it’s most effective), retain their independence longer, extend their quality of life, and ultimately spend more years with their loved ones. We are grateful for the support of The Penn AI and Tech Collaboratory for Healthy Aging and the a2 Collective | a2PilotAwards.ai in this project. We’re not just developing technology, we are nurturing hope for millions affected by Alzheimer’s disease.